High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis

Journal of Infection

Volumn 68, Issue 5, 2014, Pages 440-447

  Huang, Chun Ta ^a,b   Lee, Li Na ^a   Ho, Chao Chi ^a   Shu, Chin Chung ^a,b   Ruan, Sheng Yuan ^a   Tsai, Yi Ju ^c   Wang, Jann Yuan ^a   Yu, Chong Jen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Biomarker; C reactive protein; Procalcitonin; Prognosis; Triggering receptor expressed on myeloid cells 1; Tuberculosis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; CALCITONIN; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; PROTEIN PRECURSOR; TREM1 PROTEIN, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; MORTALITY; OUTCOME ASSESSMENT; PLEURA EFFUSION; PREDICTIVE VALUE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS; AGED; BLOOD; CHEMISTRY; MIDDLE AGED; PATHOLOGY; SERUM; SURVIVAL; TUBERCULOSIS, PULMONARY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RECEPTORS, IMMUNOLOGIC; SERUM; SURVIVAL ANALYSIS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84897959643     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.12.012     Document Type: Article

References (32)

1. Kandemir O., Uluba B., Polat G., Sezer C., Camdeviren H., Kaya A. Elevation of procalcitonin level in patients with pulmonary tuberculosis and in medical staff with close patient contact. Arch Med Res 2003, 34:311-314.
2. Karzai W., Oberhoffer M., Meier-Hellmann A., Reinhart K. Procalcitonin - a new indicator of the systemic response to severe infections. Infection 1997, 25:329-334.
3. Baylan O., Balkan A., Inal A., Kisa O., Albay A., Doganci L., et al. The predictive value of serum procalcitonin levels in adult patients with active pulmonary tuberculosis. Jpn J Infect Dis 2006, 59:164-167.
4. Rasmussen T.A., Sogaard O.S., Camara C., Andersen P.L., Wejse C. Serum procalcitonin in pulmonary tuberculosis. Int J Tuberc Lung Dis 2011, 15:251-256.
5. Ugajin M., Miwa S., Shirai M., Ohba H., Eifuku T., Nakamura H., et al. Usefulness of serum procalcitonin levels in pulmonary tuberculosis. Eur Respir J 2011, 37:371-375.
6. Chierakul N., Kanitsap A., Chaiprasert A., Viriyataveekul R. A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion. Respirology 2004, 9:66-69.
7. Schleicher G.K., Herbert V., Brink A., Martin S., Maraj R., Galpin J.S., et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J 2005, 25:688-692.
8. Richeldi L., Mariani M., Losi M., Maselli F., Corbetta L., Buonsanti C., et al. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004, 24:247-250.
9. Gibot S., Kolopp-Sarda M.N., Bene M.C., Cravoisy A., Levy B., Faure G.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141:9-15.
10. Tintinger G.R., van der Merwe J.J., Fickl H., Rheeder P., Feldman C., Anderson R. Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study. Eur J Clin Microbiol Infect Dis 2012, 31:73-76.
11. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003, 187(Suppl. 2):S397-S401.
12. Porcel J.M., Vives M., Cao G., Bielsa S., Ruiz-Gonzalez A., Martinez-Iribarren A., et al. Biomarkers of infection for the differential diagnosis of pleural effusions. Eur Respir J 2009, 34:1383-1389.
13. Chan M.C., Chang K.M., Chao W.C., Lin L.Y., Kuo B.I., Hsu J.Y., et al. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 2007, 12:333-338.
14. Liu C.L., Hsieh W.Y., Wu C.L., Kuo H.T., Lu Y.T. Triggering receptor expressed on myeloid cells-1 in pleural effusions: a marker of inflammatory disease. Respir Med 2007, 101:903-909.
15. Crump J.A., Reller L.B. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin Infect Dis 2003, 37:1037-1043.
16. Huang C.T., Tsai Y.J., Shu C.C., Lei Y.C., Wang J.Y., Yu C.J., et al. Clinical significance of isolation of nontuberculous mycobacteria in pulmonary tuberculosis patients. Respir Med 2009, 103:1484-1491.
17. Falk A.J., O'Connor B., Pratt P.C. Classification of pulmonary tuberculosis 1969, National Tuberculosis and Respiratory Disease Association, New York. 12th ed.
18. Huang L.Y., Shi H.Z., Liang Q.L., Wu Y.B., Qin X.J., Chen Y.Q. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J 2008, 121:1656-1661.
19. Bouchon A., Facchetti F., Weigand M.A., Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410:1103-1107.
20. Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993, 178:2249-2254.
21. Gerard Y., Hober D., Assicot M., Alfandari S., Ajana F., Bourez J.M., et al. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 1997, 35:41-46.
22. Prat C., Dominguez J., Andreo F., Blanco S., Pallares A., Cuchillo F., et al. Procalcitonin and neopterin correlation with aetiology and severity of pneumonia. J Infect 2006, 52:169-177.
23. Zarka V., Valat C., Lemarie E., Boissinot E., Carre P., Besnard J.C., et al. Serum procalcitonin and respiratory tract infections. Rev Pneumol Clin 1999, 55:365-369.
24. Nyamande K., Lalloo U.G. Serum procalcitonin distinguishes CAP due to bacteria, Mycobacterium tuberculosis and PJP. Int J Tuberc Lung Dis 2006, 10:510-515.
25. Gendrel D., Bohuon C. Procalcitonin, a marker of bacterial infection. Infection 1997, 25:133-134.
26. Dannenberg A.M. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991, 12:228-233.
27. Zahar J.R., Azoulay E., Klement E., De Lassence A., Lucet J.C., Regnier B., et al. Delayed treatment contributes to mortality in ICU patients with severe active pulmonary tuberculosis and acute respiratory failure. Intensive Care Med 2001, 27:513-520.
28. Matos E.D., Moreira Lemos A.C. Association between serum albumin levels and in-hospital deaths due to tuberculosis. Int J Tuberc Lung Dis 2006, 10:1360-1366.
29. Long R., O'Connor R., Palayew M., Hershfield E., Manfreda J. Disseminated tuberculosis with and without a miliary pattern on chest radiograph: a clinical-pathologic-radiologic correlation. Int J Tuberc Lung Dis 1997, 1:52-58.
30. Sharma S.K., Mohan A., Sharma A., Mitra D.K. Miliary tuberculosis: new insights into an old disease. Lancet Infect Dis 2005, 5:415-430.
31. Benator D., Bhattacharya M., Bozeman L., Burman W., Cantazaro A., Chaisson R., et al. Rifapentine and isoniazid once a week versus rifampicin and isoniazid twice a week for treatment of drug-susceptible pulmonary tuberculosis in HIV-negative patients: a randomised clinical trial. Lancet 2002, 360:528-534.
32. Burman W.J., Goldberg S., Johnson J.L., Muzanye G., Engle M., Mosher A.W., et al. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Am J Respir Crit Care Med 2006, 174:331-338.